Cnsintel

CNSintel offers confidential neuroscientific advice to drug development companies from a global network of prominent neuroscientists, in order to maximize the success rate for drug development in pre-clinical research-Our fast and affordable services enable a confidential exchange and review of ideas in neuroscience drug discovery-Obtaining advice from a multidisciplinary group of independent experts can generate new approaches that improve the success of drug development. Independent review of the scientific results at the discovery stage, or the scientific strategies for the development of new compounds, may be extremely valuable. Annual reports from the FDA and the EMA reveal that emerging CNS drugs get the some of the lowest approval rates in the United States and in the EU. It is likely that creating a safe platform to allow for the exchange and review of scientific ideas by other experts in the field may improve the success rate for the process of drug development. For more information, please visit our website at